Campaign run · Parkinson's disease

parkinson-celloracle-ko-r1

PDCompleted the pipelineSingle attempt at this topic

Does CellOracle's in-silico knock-out (KO) of the top PD-risk genes from the Kim 2024 multi-ancestry GWAS — LRRK2, GBA, SNCA, VPS13C, GAK, MAPT, BST1, CTSB, DDC, SCARB2 (10 genes ranked by fine-mapping posterior probability) — in Fullard 2024 SNpc dopaminergic neurons produce predicted cell-state vector shifts that align with the observed PD-vs-control DA state shift?

  • Supported 3
  • Not supported 2
  • Not tested (run did not execute) 1

Status

How far it got
Completed the pipeline

Tested at least one hypothesis and reached the multi-agent review stage. This shows the run went through the whole pipeline, not that its work passed a quality bar.

Hypotheses

6 nominated; 5 evaluated; 1 not tested because the run did not execute them.

Recorded status

Halted. The run recorded a final status of halted: it was closed without being marked done. A halted run can still have tested hypotheses and written a final report.

Census class

Success. Census class is a label from an earlier, process-level census of the campaign. It does not map one-to-one onto the stages above. How the classes compare.

Research question

The sentence under the run id is quoted from this brief.

Full research brief given to the run

Does CellOracle's in-silico knock-out (KO) of the top PD-risk genes from the Kim 2024 multi-ancestry GWAS — LRRK2, GBA, SNCA, VPS13C, GAK, MAPT, BST1, CTSB, DDC, SCARB2 (10 genes ranked by fine-mapping posterior probability) — in Fullard 2024 SNpc dopaminergic neurons produce predicted cell-state vector shifts that align with the observed PD-vs-control DA state shift?

The CellOracle framework (Kamimoto et al. 2023 Nature) lets one combine a scATAC-derived base-GRN with snRNA-seq to predict counter-factual cell-state shifts in response to TF / target perturbation. The mechanistic-content claim — that the inferred GRN encodes enough biology to predict disease-state shifts — has not been formally tested in human PD with public data.

Hypotheses (pre-registered):

H1 (primary — KO-vs-disease alignment): The mean cosine similarity between the CellOracle-predicted post-KO state-shift vector (averaged across the 10 GWAS genes) and the observed PD-minus-control SNpc DA centroid shift is > 0.30, with a permutation-null p < 0.01 (10,000 random gene-label permutations).

H2 (secondary — fine-mapping PIP correlation): Per-gene KO cosine alignment with PD-minus-control shift correlates positively (Spearman ρ > 0.4, p < 0.05) with the gene's posterior probability of causal association from Kim 2024 fine-mapping (Supp Table S5).

H3 (secondary — LRRK2-KO target enrichment): The CellOracle-predicted top-100 up-regulated targets of LRRK2-KO are enriched (q < 0.05 by hypergeometric) for the Hemedan 2024 Boolean-PD "prodromal-cluster" regulatory-module gene list.

H4 (secondary — SNCA protective + HBB null control): SNCA-KO simulation predicts a protective shift (cosine with PD-vs-ctrl vector > 0 with permutation p < 0.05), consistent with α-syn loss-of-function reducing aggregation; control gene HBB (red-blood-cell marker, irrelevant) predicts a null shift (|cosine| < 0.1).

H5 (secondary — base-GRN robustness): Repeat the analysis with the published CellOracle midbrain reference base-GRN (Zenodo 7755357) vs. the Adams-2024- derived ATAC base-GRN. The H1 cosine-similarity changes by ≤ 0.1 between the two base-GRN sources (network-source sensitivity test).

Null payoff. A null cosine alignment (H1 ≤ 0.15) means GWAS- implicated genes do not in-silico recapitulate PD cellular phenotypes — sharpening the long-standing field critique that risk-variant biology is not cell-autonomous and may be glia-mediated.

The research question comes from the topic's current research brief. All attempts at a topic share it; earlier attempts may have started from an earlier wording.

Hypotheses and verdicts

Each hypothesis was written with its decision rule before any analysis (or, for on-the-fly hypotheses, recorded during execution). AI adjudication agents applied that rule to the run's latest outputs and quoted the evidence verbatim. Where the data did not meet the rule, the verdict follows the data, even if the run's own label or report claimed support.

Each hypothesis as pre-registered (a condensed statement with its decision rule), the adjudicated verdict, the verbatim evidence and the adjudicator's note.
IDHypothesis and decision ruleVerdict
H1Pre-registeredMean cosine between in-silico KO shift (10 GWAS genes) and PD-minus-control DA shift >0.30 with permutation p<0.01Not supportedIn the explorer

Evidence (verbatim from the run outputs)

H1 verdict: NOT SUPPORTED at the pre-registered threshold (threshold = cosine > 0.30). The mean cosine of 0.025 does not reach 0.30.

Adjudication note

Permutation component met (p=0.001 vs null mean -0.135) but cosine CI [-0.067,0.114] includes 0; residualized delta p=0.43. CellOracle not run (velocyto build failure) - expression-stratification proxy; DMNX_Neu fallback instead of SNpc. Could arguably be PARTIALLY_SUPPORTED (one of two rule components met).

H2Pre-registeredPer-gene KO alignment correlates with fine-mapping PIP (Spearman rho>0.4, p<0.05; n=10)Not supportedIn the explorer

Evidence (verbatim from the run outputs)

H2 NOT SUPPORTED (ρ threshold = 0.4, p threshold < 0.05).

Adjudication note

rho=0.042; pre-flagged ~30% power.

H3Pre-registeredLRRK2-KO top-100 predicted targets enriched for Hemedan 2024 prodromal module (BH q<0.05)SupportedIn the explorer

Evidence (verbatim from the run outputs)

H3 SUPPORTED (q < 0.05). LRRK2-KO predicted targets are significantly enriched in the Hemedan 2024 Boolean-PD prodromal regulatory module (FDR q = 0.007, FE = 4.7×).

Adjudication note

Overlap is 5 genes (SNCA, LRRK2, GAK, CTSB, SCARB2) in an 11-gene HVG-restricted module; overlapping genes are themselves GWAS/KO genes (possible circularity). Proxy KO method, not CellOracle.

H4aPre-registeredSNCA-KO predicts protective shift: cosine with PD-vs-ctrl vector >0, permutation p<0.05SupportedIn the explorer

Evidence (verbatim from the run outputs)

- SNCA-KO: cosine = +0.235, permutation p = 0.001 (one-tailed: cosine ≥ 0.235 in null). H4a SUPPORTED

Adjudication note

Literal rule met. Interpretive incoherence: positive cosine means KO shifts TOWARD the PD state, yet text calls it 'protective'.

H4bPre-registeredHBB-KO negative control predicts null shift (|cosine|<0.1)SupportedIn the explorer

Evidence (verbatim from the run outputs)

- HBB-KO: |cosine| = 0.032 < 0.1 threshold. H4b SUPPORTED

Adjudication note

Report notes residualized HBB cosine rises to 0.236; raw (primary) value used.

H5Pre-registeredH1 mean cosine changes <=0.1 between Adams-derived ATAC base-GRN and Zenodo midbrain reference base-GRNNot runIn the explorer

Evidence (verbatim from the run outputs)

The Zenodo midbrain reference base-GRN comparison was not executed (CellOracle package unavailable due to velocyto build failure; Zenodo download was not attempted).

Adjudication note

Surrogate raw-vs-residualized comparison gave |delta|=0.118 (>0.1); report reports H5 'not formally supported' on the surrogate.